No linked studies yet.
Product analysis
Omega 3 Fish Oil offers EPA and DHA for triglyceride-related support, with good value for these active fats. Their forms are undisclosed, which makes absorption quality harder to compare.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The active-fat forms are unspecified, leaving absorption quality uncertain. Their stated amounts do not resolve how the oil was prepared.
Ingredient Transparency70
Amounts and active-fat proportions are disclosed, separating EPA and DHA from the total oil. The forms are unspecified, so preparation quality remains harder to compare.
Value For Money92
EPA offers very good value, and DHA also compares favorably at the full serving cost. That makes the oil appealing when those active fats are the reason to buy.
Customer Satisfaction80
Customer ratings indicate strong satisfaction. Several hundred ratings provide a useful spread of buyer feedback.
Product Focus76
The clearest purpose involves triglyceride-related support rather than broad heart-event prevention. Other possible benefits are less consistent, and the brain-nutrition findings do not establish immediate focus.
- Format
Softgel - Container
- 180 Softgel(s)
- Per serving
- $0.47
- Customer rating
- 4.8 · 606 ratings
Goals
EPA offers triglyceride-related support, while DHA has limited evidence for selected lipid and vascular measures. The explicit fatty-acid declarations distinguish their amounts from the fish-oil carrier, which supplies no extra active dose. Prescription purified EPA outcomes in selected high-risk patients do not establish the same benefit for this supplement, and routine primary-prevention findings did not show fewer major cardiovascular events.
How this product is rated for Heart Health
Ingredient fit90
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence100
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
The declared EPA and DHA amounts relate to triglyceride metabolism. Oral studies support triglyceride lowering, but the supplied study exposures were higher than these declared component amounts per serving. This is support for a blood-fat marker, with no established general prevention of cardiovascular events.
How this product is rated for Cardiovascular Support
Ingredient fit88
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence83
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
EPA and DHA contribute to fatty-acid pathways involved in inflammation, and some trials report reductions in inflammatory markers. Findings are inconsistent across doses and populations, so routine clinical benefit is not established. The separately declared EPA and DHA amounts are considered without treating total oil or unspecified fatty acids as combined active content.
How this product is rated for Inflammation
Ingredient fit70
Goal fit
Dose adequacy
Pathways42
Depth
Breadth
Evidence70
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
DHA and EPA relate to longer-term brain nutrition rather than immediate focus. Positive DHA findings involved repeated use in adults with low intake and mainly memory or reaction-time outcomes. Long-term omega-3 results are mixed, so these findings do not establish an acute concentration benefit.
How this product is rated for Mental Focus
Ingredient fit81
Goal fit
Dose adequacy
Pathways60
Depth
Breadth
Evidence56
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
No linked studies yet.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Calories from Fat | 20 Calorie(s) | |
Total Fat | 2 Gram(s) | |
Fish Oil | 2000 mg | |
Eicosapentaenoic Acid | 800 mg | |
Docosahexaenoic Acid | 600 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability58
Molecular Form and Bioavailability
EPA Concentration Density
Oxidation Protection
Dose, Safety & Label Transparency91
Absolute EPA Dose per Serving
EPA-Centric Ratio
Purity and Contaminant Testing
Value100
Price per Gram of EPA
How this ingredient is rated
Active Ingredient Quality & Bioavailability61
Omega-3 Molecular Form
Purification & Filtration Method
Third-Party Purity & Potency Verification
Source & Sustainability
Dose, Safety & Label Transparency78
Total Active Omega-3 Dose (EPA + DHA)
Omega-3 Potency & Concentration
EPA & DHA Individual Disclosure
Oxidation Protection (Stabilizers)
Value100
Cost Per Gram of Active EPA + DHA
How this ingredient is rated
Active Ingredient Quality & Bioavailability42
DHA Chemical Form & Bioavailability
Oxidation Protection & Stability
Oil Concentration & Purity
Dose, Safety & Label Transparency95
DHA Absolute Dosage
Purity & Heavy Metal Verification
Ingredient Source Transparency
Value80
Price per Gram of DHA
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
- Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
- A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
- Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
- Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
- Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
- Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
- Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
- Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
- Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
- Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
- Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
- The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
- Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
- EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
- Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
- Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.